Adrianna Szczecińska

Adrianna Szczecińska

Auto-generated profile, based on publicly available information

Adrianna Szczecińska

University Clinical Hospital in Poznan, 49 Przybyszewskiego Street, 60-355 Poznan, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
JBJakub Bajer
Jakub Bajer
AWAleksandra Włodarczyk
Aleksandra Włodarczyk
HKHubert Kulawinek
Hubert Kulawinek
JOJulia Obersztyn
Julia Obersztyn
KKKrzysztof Kasparek
Krzysztof Kasparek
PMPiotr Mrozek
Piotr Mrozek
Background. Post-Traumatic Stress Disorder (PTSD) is an important public health challenge typically treated with trauma-focused psychotherapy and Selective Serotonin Reuptake Inhibitors (SSRIs). However, high rates of residual symptoms associated with these standard treatments have led to a renewed interest in psychedelic-assisted therapies. Aim. This review attempts to examine emerging psychedelic therapies in the management of PTSD, with a primary focus on 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and ketamine. Material and methods. A literature search was carried out using PubMed, Google Scholar, and Scopus to identify relevant studies using keywords such as 'PTSD', 'MDMA', 'psychedelics', 'ketamine', 'psychedelic-assisted therapy', 'neuroplasticity', and 'fear extinction'. Results. Psychedelics induce neuroplasticity and augment fear extinction, primarily through the AMPAR-BDNF-TrkB-mTOR pathway and 5-HT2A receptors. MDMA-assisted therapy demonstrates high efficacy, with a trial showing that 67% of participants no longer met PTSD criteria at the study endpoint. Psilocybin effectively treats common comorbidities like anxiety and treatment-resistant depression. Ketamine offers rapid symptom alleviation, making it notably beneficial for treatment-resistant cases with a high risk of self-harm and suicide. Conclusions. Psychedelic therapies, particularly MDMA-assisted therapy, represent a potential breakthrough by targeting the underlying causes of PTSD rather than merely suppressing symptoms. In spite of current regulatory problems, they hold meaningful promise, pointing out the need for standardized treatment protocols to ensure safety and reproducibility in future research.

10 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JOJulia Obersztyn
Julia Obersztyn
ASAdrianna Szczecińska
Adrianna Szczecińska
HKHubert Kulawinek
Hubert Kulawinek
AMAleksandra Mliczek
Aleksandra Mliczek
GKGrzegorz Kasparek
Grzegorz Kasparek
MCMarta Czech
Marta Czech
Introduction: Iron deficiency is one of the most common micronutrient deficiencies in athletes, particularly in endurance athletes and women. The effectiveness of oral iron supplementation depends not only on the dose but also on supplementation timing, dosing frequency, and hepcidin regulation. Aim: To summarize current evidence on oral iron supplementation strategies in athletes, with particular emphasis on the role of hepcidin in optimizing iron absorption. Material and methods: A literature search was conducted through PubMed (MEDLINE) and Google Scholar. Randomized controlled trials, stable-isotope studies, and review articles published in English up to February 2026 were analyzed. Results: Current evidence suggests that alternate-day, low-dose oral iron supplementation improves gastrointestinal tolerance and may enhance iron absorption compared with daily dosing. Iron absorption is influenced by circadian rhythm and exercise-induced increases in hepcidin, making supplementation timing clinically important. Conventional ferrous salts remain the first-line treatment, whereas novel formulations and intravenous iron may be appropriate in selected cases. Conclusions: Iron supplementation should be individualized according to iron status, training schedule, treatment tolerance, and clinical needs. Optimizing dosing frequency and timing represents a simple strategy to improve treatment effectiveness. Further athlete-specific studies are needed to establish evidence-based recommendations.

29 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MCMarta Czech
Marta Czech
JOJulia Obersztyn
Julia Obersztyn
PMPiotr Mrozek
Piotr Mrozek
AMAleksandra Mliczek
Aleksandra Mliczek
HKHubert Kulawinek
Hubert Kulawinek
ASAdrianna Szczecińska
Adrianna Szczecińska
Background. Proper postoperative wound healing is an essential and ongoing component of effective hospital care. Cigarette smoking might be one of the modifiable risk factors for impaired wound healing, which can lead to prolonged hospitalization and increased healthcare costs. Objective. This systematic review examined existing literature on the documented impact of cigarette smoking on the incidence and types of postoperative wound-healing complications by comparing smokers with non-smokers and whether preoperative smoking cessation significantly reduces the risk of these complications. Methods. A structured literature review was conducted using PubMed, Elsevier, ScienceDirect and Scopus were searched between June and August 2026. Studies included systematic reviews, meta-analyses, cohort studies, and review articles published between 2000 and 2025 Results. Smoking cigarettes disrupts the functioning of our body and is associated with numerous disorders and impairs postoperative wound healing. Importantly, these adverse outcomes may be reduced through effective smoking cessation interventions. Conclusion. Smoking cessation before surgery is an important strategy for reducing postoperative complications, healthcare costs, and mortality. Preferably, smoking should be stopped at least 4–6 weeks before elective surgery and continued for 4–8 weeks postoperatively to maximize the potential benefits. Overall, quitting smoking improves surgical outcomes and can be lifesaving.

13 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AMAleksandra Mliczek
Aleksandra Mliczek
BRBrajan Roczyński
Brajan Roczyński
IPIzabela Polok
Izabela Polok
JOJulia Obersztyn
Julia Obersztyn
ASAdrianna Szczecińska
Adrianna Szczecińska
Background. Rising global obesity prevalence has coincided with a debated decline in semen quality. GLP-1 receptor agonists (GLP-1 RAs) are now widely used for weight reduction in men of reproductive age, raising questions about their effect on fertility, particularly relative to testosterone replacement therapy (TRT), which suppresses spermatogenesis. Aim. To review evidence on GLP-1 RAs and the male reproductive system, focusing on semen parameters and the hypothalamic-pituitary-gonadal axis, and whether effects are drug-specific or mediated by weight loss. Material and methods. Narrative review of PubMed, Scopus and Web of Science on GLP-1 RAs, semen quality, male fertility, testosterone, functional hypogonadism, obesity and weight loss, with reference-list screening and ClinicalTrials.gov. English-language studies only; no time restriction. Results. GLP-1 receptors are expressed in human testis and spermatozoa. Obesity impairs semen quality via endocrine, inflammatory and thermal mechanisms. GLP-1 RAs raise testosterone while preserving gonadotropic function, unlike TRT; a randomized trial showed semaglutide improved sperm morphology while testosterone worsened sperm count. Weight loss, not the drug itself, appears the principal mediator, as exercise gave comparable benefit to liraglutide. Bariatric surgery did not reliably improve semen quality. Sexual-function data remain conflicting. Evidence is limited by small samples and short follow-up. Conclusions. GLP-1 RAs appear reproductively safe and may improve semen parameters in men with obesity-related functional hypogonadism, offering a fertility-sparing alternative to TRT. Benefit is largely attributable to weight loss; lifestyle intervention remains reasonable first-line. Larger, longer trials, including tirzepatide, are needed.

17 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
JOJulia Obersztyn
Julia Obersztyn
AMAleksandra Mliczek
Aleksandra Mliczek
ASAdrianna Szczecińska
Adrianna Szczecińska
BRBrajan Roczyński
Brajan Roczyński
IPIzabela Polok
Izabela Polok
KŁKinga Łompieś
Kinga Łompieś
Introduction. Hypercholesterolemia is typically associated with obesity and metabolic syndrome, yet elevated total and LDL cholesterol are also frequently observed in underweight individuals, including patients with anorexia nervosa (AN). This paradox can cause diagnostic uncertainty when lipid results are interpreted based on concepts derived from obesity-related dyslipidemia. Aim. To summarize current evidence on mechanisms underlying hypercholesterolemia in underweight individuals, with emphasis on AN, and to outline its clinical significance and management. Materials and Methods. A narrative review of PubMed and Google Scholar literature published up to July 2026, prioritizing systematic reviews, meta-analyses, and observational studies on lipid abnormalities in underweight populations. Results. Hypercholesterolemia in starvation states arises from reduced hepatic LDL-receptor activity, a low-T3 endocrine state, altered cortisol, insulin and leptin signalling, impaired bile acid synthesis, and altered lipoprotein transport, rather than dietary cholesterol intake. These adaptations differ from obesity-driven dyslipidemia and generally improve with nutritional rehabilitation. Conclusions. Hypercholesterolemia associated with underweight is usually a reversible metabolic adaptation to prolonged energy deficiency. Nutritional rehabilitation should be the primary treatment strategy, whereas persistent lipid abnormalities after weight restoration require further diagnostic evaluation.

29 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
GKGrzegorz Kasparek
Grzegorz Kasparek
KKKrzysztof Maksym Kasparek
Krzysztof Maksym Kasparek
JOJulia Obersztyn
Julia Obersztyn
JBJakub Maksymilian Bajer
Jakub Maksymilian Bajer
HKHubert Kulawinek
Hubert Kulawinek
MCMarta Czech
Marta Czech
Erysipelas is an acute bacterial infection of the upper dermis and superficial lymphatic vessels. Beta hemolytic streptococci cause most typical cases. The disease often starts suddenly with painful erythema, warmth, swelling, fever, chills, and a raised or sharply demarcated skin border. Most patients respond to antibiotic therapy, but recurrent episodes can damage lymphatic drainage and create chronic edema. This narrative review summarizes current evidence on etiology, risk factors, clinical variants, diagnosis, treatment, complications, prevention, and care organization. It gives special attention to recurrent lower limb disease, because recurrence links infection with mobility loss, work absence, repeated antibiotic exposure, compression therapy, community nursing, and social support. The review also distinguishes infectious erysipelas from carcinoma erysipeloides, a malignant mimic that can delay cancer diagnosis when clinicians treat persistent erythema as infection.